Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Liesner

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 7, 2005
Management of neonates with inherited bleeding disorders--a survey of current UK practiceE A Chalmers, M D Williams, M Richards, et al.
Brain : a Journal of Neurology|February 9, 2005
Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcomeG Sébire, B Tabarki, D E Saunders, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 11, 2014
The incidence of factor VIII inhibitors in severe haemophilia A following a major switch from full-length to B-domain-deleted factor VIII: a prospective cohort comparisonC R M Hay, B P Palmer, E A Chalmers, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 13, 2010
Treatment related factors and inhibitor development in children with severe haemophilia AP S Maclean, M Richards, M Williams, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|February 9, 2006
Perinatal renal venous thrombosis: presenting renal length predicts outcomeP J D Winyard, T Bharucha, R De Bruyn, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 16, 2017
Vaccinations are not associated with inhibitor development in boys with severe haemophilia AH Platokouki, K Fischer, S C Gouw, et al.
Journal of Thrombosis and Haemostasis : JTH|April 28, 2015
Recombinant factor VIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia AG Young, J Mahlangu, R Kulkarni, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 3, 2018
Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Executive CommitteeP W Collins, R Liesner, M Makris, et al.
Neurology|January 28, 2004
Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in childrenS Lanthier, F J Kirkham, L G Mitchell, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 3, 2017
First-line immune tolerance induction for children with severe haemophilia A: A protocol from the UK Haemophilia Centre Doctors' Organisation Inhibitor and Paediatric Working PartiesP Collins, E Chalmers, J Alamelu, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 7, 2005
Management of neonates with inherited bleeding disorders--a survey of current UK practiceE A Chalmers, M D Williams, M Richards, et al.
Brain : a Journal of Neurology|February 9, 2005
Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcomeG Sébire, B Tabarki, D E Saunders, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 11, 2014
The incidence of factor VIII inhibitors in severe haemophilia A following a major switch from full-length to B-domain-deleted factor VIII: a prospective cohort comparisonC R M Hay, B P Palmer, E A Chalmers, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 13, 2010
Treatment related factors and inhibitor development in children with severe haemophilia AP S Maclean, M Richards, M Williams, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|February 9, 2006
Perinatal renal venous thrombosis: presenting renal length predicts outcomeP J D Winyard, T Bharucha, R De Bruyn, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 16, 2017
Vaccinations are not associated with inhibitor development in boys with severe haemophilia AH Platokouki, K Fischer, S C Gouw, et al.
Journal of Thrombosis and Haemostasis : JTH|April 28, 2015
Recombinant factor VIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia AG Young, J Mahlangu, R Kulkarni, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 3, 2018
Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Executive CommitteeP W Collins, R Liesner, M Makris, et al.
Neurology|January 28, 2004
Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in childrenS Lanthier, F J Kirkham, L G Mitchell, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 3, 2017
First-line immune tolerance induction for children with severe haemophilia A: A protocol from the UK Haemophilia Centre Doctors' Organisation Inhibitor and Paediatric Working PartiesP Collins, E Chalmers, J Alamelu, et al.
Pageof 7